The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allied Minds forms cancer drug arm with NYU School of Medicine

Wed, 16th Mar 2016 08:08

(ShareCast News) - Allied Minds has launched a new subsidiary to develop potential cancer drugs from compounds developed by the New York University School of Medicine.Allied's joint venture with pharma group Bristol-Myers Squibb, Allied-Bristol Life Sciences, has set up the subsidiary, called ißeCa Therapeutics, with a licensing agreement from NYU to develop a group of compounds that seem to reduce cancerous tumour growth.The license to this technology will be held by ißeCa Therapeutics, which will focus on completing further research and pre-clinical characterization so that a development candidate can be progressed to investigational new drug (IND) enabling studies and beyond.Focusing on the 'Wnt' signalling pathway that regulates cell function in the human body, the NYU compounds contain inhibitors of ß-Catenin responsive transcription (iCRTs) that are able to reduce tumour growth by inhibiting the abnormal Wnt function in tumour cells.The Wnt pathway plays a key role in the development and progression of a number of cancers affecting large numbers of patients.The ißeCa subsidiary will to help continue discovery and development activities needed to identify candidates for human clinical testing.NYU research associate professor Ramanuj Dasgupta said the work was at a critical point in its translation, "where the resources and expertise of the ABLS team will make the difference in bringing these novel cancer therapies to patients as quickly as possible".The licensing agreement with NYU School of Medicine is the third in a series of discovery and development projects that Allied-Bristol Life Sciences is pursuing.
More News
4 Feb 2016 10:28

WINNERS & LOSERS SUMMARY: Shell Gains As Earnings Meet Expectations

Read more
4 Feb 2016 08:51

Allied Minds demonstrates new memory technology

(ShareCast News) - A new, more versatile form of memory, with potential applications from smartphones to the automotive industry, was a step closer on Thursday, with Allied Minds announcing the successful demonstration of a prototype of 'Spin Transfer Magneto-Resistive Random Access Memory' (ST-MRAM

Read more
4 Feb 2016 07:54

Allied Minds Subsidiary Achieves Success With New Memory Technology

Read more
3 Feb 2016 16:14

FTSE 250 movers: Banking and investment firms drive market down

(ShareCast News) - The FTSE 250 was down 289.58 points (1.78%) to 16,010.10 shortly before the close on Wednesday. Allied Minds continued to fall after rising earlier in the week on the back of news its subsidiary Federated Wireless completed a successful $22m (£15.4m) Series A Preferred fundraising

Read more
2 Feb 2016 15:33

FTSE 250 movers: Investors worried about Ocado Smart Platform partners

(ShareCast News) - The FTSE 250 continued to slide on Tuesday, with the second tier market down 249.75 points (1.51%) to 16,239.51 points by mid-afternoon. Despite posting double-digit revenue growth for the year through "challenging market conditions", shares in Ocado Group were down over 8%. T

Read more
1 Feb 2016 15:13

FTSE 250 movers: Vedanta and Just Eat fall on broker notes

(ShareCast News) - The FTSE 250 started the month in the red, down 68.05 points (0.41%) to 16,419.67 by mid-afternoon on Monday. Vedanta Resources sank after Deutsche Bank cuts its target price for the mining company from 200p to 185p on lower than expected iron ore sales. The bank said Vedanta now

Read more
1 Feb 2016 14:13

Broker tips: Allied Minds, Premier Oil, Domino's, Just Eat

(ShareCast News) - Shares in Allied Minds gained on Monday as Numis reiterated the stock at 'buy' after the company announced a successful $22m (£15.4m) fundraising for its subsidiary Federated Wireless. The US-based FTSE 250 science and technology developer invested $5m in the fundraising and the r

Read more
1 Feb 2016 12:41

Numis reiterates 'buy' at Allied Minds

(ShareCast News) - Shares in Allied Minds gained on Monday as Numis reiterated the stock at 'buy' after the company announced a successful $22m (£15.4m) fundraising for its subsidiary Federated Wireless. The US-based FTSE 250 science and technology developer invested $5m in the fundraising and the r

Read more
1 Feb 2016 12:07

LONDON MARKET MIDDAY: BT Group Leads Blue-Chips In Mixed Market

Read more
1 Feb 2016 10:20

WINNERS & LOSERS SUMMARY: BT Shares Up As Profit And Revenue Rise

Read more
1 Feb 2016 08:07

Allied Minds raises £15m to develop wireless technology

(ShareCast News) - Allied Minds was looking at a beefed-up Federated Wireless subsidiary on Monday, announcing the a successful $22m (£15.4m) Series A Preferred fundraising round for the firm. The US-based FTSE 250 science and technology developer said the equity had come from investors including Wo

Read more
1 Feb 2016 07:42

Allied Minds Invests In USD22 Million Federated Wireless Fundraising

Read more
4 Jan 2016 14:10

FTSE 250 movers: Ocado keeps falling, Allied Minds lifted by paper tip

(ShareCast News) - With less exposure to international companies than the blue chip benchmark, the FTSE 250 index was down 1.5% by mid afternoon, compared to the 2%-plus dip of the FTSE 100. Worries about China were the cause of the widespread losses in London, Europe and the US on Monday, but the U

Read more
3 Jan 2016 14:47

Sunday share tips: Persimmon, Vodafone, McBride, Telford Homes

(ShareCast News) - Now might be the right time to sell Persimmon shares, said the Sunday Times' Inside the City column, with a trading update due on Thursday. Investors in the house builder have seen the price triple in the last three years and received £800m in dividends. Persimmon was one of three

Read more
5 Oct 2015 16:03

London close: Stocks end higher despite negative services data

(ShareCast News) - UK stocks gained as the market proved resilient against a batch of negative services data on hopes the Federal Reserve will keep interest rates unchanged for longer. The Markit/CIPS UK services purchasing managers' index fell to 53.3 in September from 55.6 in August, compared to a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.